Evidence map›Paper›PMID 27638942›Full record

ArticleThe Journal of infectious diseases2017

Humanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia.

Alice Prince, Hui Wang, Kipyegon Kitur, Dane Parker

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. GrowingInfection and immunity · 2026
    Article
  2. Article
  3. Article
  4. Sympathetic regulation of the host immune response to bacterial sepsis.Clinical science (London, England : 1979) · 2025
    Review
  5. Article
  6. A promisingClinical and experimental vaccine research · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Immune Checkpoint Molecules as Biomarkers ofbioRxiv : the preprint server for biology · 2024
    Article
  11. Humanized Mouse Models of Bacterial Infections.Antibiotics (Basel, Switzerland) · 2024
    Review
  12. LinkingAntibiotics (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Clinical Impact ofAntibiotics (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Alice PrinceDepartment Pediatrics.
Hui WangHumanized Mouse Core Facility, Columbia Center for Translational Immunology, Columbia University, New York.
Kipyegon KiturDepartment of Pharmacology, and.
Dane ParkerDepartment Pediatrics.

Funding

Innate Immune Clearance of Host-Adapted Pulmonary PathogensR35HL135800 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S · 2017 to 2023
$5.9M
STAPHYLOCOCCUS AUREUS ACTIVATION OF TNF SIGNALING PATHWAYSR01HL079395 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S · 2006 to 2016
$4.3M
NHLBI NIH HHS R01 HL079395NHLBI NIH HHS R35 HL135800
6 · The paper itself

Abstract

Staphylococcus aureus is a highly successful human pathogen that has evolved in response to human immune pressure. The common USA300 methicillin-resistant S. aureus (MRSA) strains express a number of toxins, such as Panton-Valentine leukocidin and LukAB, that have specificity for human receptors. Using nonobese diabetic (NOD)-scid IL2Rγnull (NSG) mice reconstituted with a human hematopoietic system, we were able to discriminate the roles of these toxins in the pathogenesis of pneumonia. We demonstrate that expression of human immune cells confers increased severity of USA300 infection. The expression of PVL but not LukAB resulted in more-severe pulmonary infection by the wild-type strain (with a 30-fold increase in the number of colony-forming units/mL; P < .01) as compared to infection with the lukS/F-PV (Δpvl) mutant. Treatment of mice with anti-PVL antibody also enhanced bacterial clearance. We found significantly greater numbers (by 95%; P < .05) of macrophages in the airways of mice infected with the Δpvl mutant compared with those infected with the wild-type strain, as well as significantly greater expression of human tumor necrosis factor and interleukin 6 (84% and 51% respectively; P < .01). These results suggest that the development of humanized mice may provide a framework to assess the contribution of human-specific toxins and better explore the roles of specific components of the human immune system in protection from S. aureus infection.

Indexed as

AnimalsBacterial ToxinsCytokinesDisease Models, AnimalDisease SusceptibilityExotoxinsHost-Pathogen InteractionsHumansLeukocidinsMiceMice, Inbred NODMice, TransgenicPneumonia, StaphylococcalStaphylococcus aureusBacterial ToxinsCytokinesExotoxinsLeukocidinsPanton-Valentine leukocidinhost-pathogenhumanizedlungmouse modelPanton-Valentine leukocidinpneumoniaPVLrespiratoryStaphylococcus aureus

Identifiers

PMID27638942
PMCPMC5853420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.